After speedrunning a series of major manufacturing milestones in the past year and a half, the “biotech floodgates” have ...

Teva Pharmaceuticals (TEVA) secures exclusive global rights to a biosimilar candidate targeting Roche’s (RHHBY) multiple ...

An anonymous NFC executive had two words to describe New York Jets linebacker Demario Davis ahead of the 2026 season.

The State Courts are partnering community organisations to expand rehabilitation efforts for offenders even before sentencing ...

Andy Burnham's decision to stick with Rachel Reeves's fiscal rules and moderate some of his more radical policies have led ...

Therapy dogs known as "Canines for Kindness" assist in the healing journey for families impacted by the July 4th flooding in ...

New biotech Avere Therapeutics has taken a fast-track to becoming a publicly listed company by merging with NextCure, with a ...

AstraZeneca has added another piece to its sprawling interface with CSPC Pharmaceutical, paying the Chinese biotech $30 million upfront to jointly discover and develop two kidney disease drug ...

Glazed in sweat and surrounded by swirls of steam, Tyler Hart and Bill Robertson made an informal pact that would eventually ...

Alector faces a strategic reset after GSK’s termination of their neuroscience collaboration, shifting the investment case to ...

Insilico Medicine and China Medical System Holdings announced on July 12, 2026, a second AI-driven drug discovery collaboration in fewer than three months, with the specific brain-disease target ...

June 2026 saw drug development in oncology and neurology continue and biotech deals over small molecules and RNA therapies ...